Management of patients with stroke: Is it time to expand treatment options?

Annals of Neurology

Volumn 74, Issue 1, 2013, Pages 4-10

  Adams, Harold P ^a   Nudo, Randolph J ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; EPHRIN A5; FLUOXETINE; NEUROPROTECTIVE AGENT; PLACEBO; PROTEOCHONDROITIN SULFATE;

ARTICLE; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; COMPARATIVE STUDY; GENE THERAPY; HUMAN; LABORATORY; LONG TERM CARE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL;

EID: 84883288908     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23948     Document Type: Article

References (82)

1. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
2. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebravasc Dis 2008; 25: 457-507.
3. Adeoye O, Hornung R, Khatri P, Kleindorfer D,. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011; 42: 1952-1955.
4. Carter AR, Connor LT, Dromerick AW,. Rehabilitation after stroke: current state of the science. Curr Neurol Neurosci Rep 2010; 10: 158-166.
5. Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36: e100-e143.
6. Jones TA, Allred RP, Adkins DL, et al. Remodeling the brain with behavioral experience after stroke. Stroke 2009; 40: S136-S138.
7. Nudo RJ, Wise BM, SiFuentes F, Milliken GW,. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996; 272: 1791-1794.
8. Wolf SL, Winstein CJ, Miller JP, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006; 296: 2095-2104.
9. National Institute of Neurological Disorders and Stroke. Post-stroke rehabilitation fact sheet. NIH Publication 80-4846. Bethesda, MD: NIH, 2008.
10. Dromerick AW, Lang CE, Birkenmeier RL, et al. Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): a single-center RCT. 2009; 73: 195-201.
11. Wolf SL, Winstein CJ,. Intensive physical therapeutic approaches to stroke recovery. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 219-231.
12. Langhorne P, Bernhardt J, Kwakkel G,. Stroke rehabilitation. Lancet 2011; 377: 1693-1702.
13. Harvey RL, Nudo RJ,. Cortical brain stimulation: a potential therapeutic agent for upper limb motor recovery following stroke. Top Stroke Rehabil 2007; 14: 54-67.
14. Plow EB, Carey JR, Nudo RJ, Pascual-Leone A,. Invasive cortical stimulation to promote recovery of function after stroke: a critical appraisal. Stroke 2009; 40: 1926-1931.
15. Sharma N, Cohen LG,. Recovery of motor function after stroke. Dev Psychobiol 2012; 54: 254-262.
16. Barbay S, Nudo RJ,. The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal. Neurorehabilitation 2009; 25: 5-17.
17. Fang PC, Barbay S, Plautz EJ, et al. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke 2010; 41: 544-549.
18. Jones TA, Liput DJ, Maresh EL, et al. Use-dependent dendritic regrowth is limited after unilateral controlled cortical impact to the forelimb sensorimotor cortex. J Neurotrauma 2012; 29: 1455-1468.
19. Cramer SC, Riley JD,. Neuroplasticity. Curr Opinion Neurol 2008; 21: 76-82.
20. Nudo RJ,. Neural bases of recovery after brain injury. J Commun Disord 2011; 44: 515-520.
21. Liauw J, Hoang S, Choi M, et al. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab 2008; 28: 1722-1732.
22. Cramer SC,. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol 2008; 63: 272-287.
23. Cramer SC, Riley JD,. Brain repair after stroke. N Engl J Med 2010; 362: 1827-1829.
24. Caplan LR, Arenillas J, Cramer SC, et al. Stroke-related translational research. Arch Neurol 2011; 68: 1110-1123.
25. Kleim JA, Schwerin S,. Motor map plasticity: a neural substrate for improving motor function after stroke. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 1-10.
26. Carmichael ST,. Molecular mechanisms of neural repair after stroke. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 11-21.
27. Li Y, Chopp M,. Cellular approaches to stroke recovery. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 267-274.
28. Carmichael ST, Archibeque I, Luke L, et al., Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol 2005; 193: 291-311.
29. Comelli MC, Guidolin D, Seren MS, et al. Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke. Neuroscience 1993; 55: 473-490.
30. Muller HD, Hamamanthiale KM, Diederich K, et al. Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Stroke. 2008; 39: 1012-1021.
31. Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor and forced arm use on functional motor recovery after small cortical ischemia. Stroke. 2004; 35: 992-997.
32. Ren J, Kaplan PL, Charette MF, et al. Time window for intracisternal osteogenic protein-1 in enhancing functional recovery after stroke. Neuropharmacol. 2000; 39: 860-865.
33. Lee JK, Kim JE, Sivula M, Strittmatter SM,. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004; 24: 6209-6217.
34. Papadopoulos CM, Tsai SY, Cheatwood JL, et al. Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex 2006; 16: 529-536.
35. Tsai SY, Papadopoulos CM, Schwab ME, Kartje GL,. Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats. Stroke 2011; 42: 186-190.
36. Dickendesher TL, Baldwin KT, Mironova YA, et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 2012; 15: 703-712.
37. Overman JJ, Clarkson AN, Wanner IB, et al. A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc Natl Acad Sci U S A 2012; 109: E2230-E2239.
38. Zhang R, Wang Y, Zhang L, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 2002; 33: 2675-2680.
39. Wang L, Zhang Z, Wang Y, et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35: 1732-1737.
40. Hossmann KA, Buschmann IR,. Granulocyte-macrophage colony-stimulating factor as an arteriogenic factor in the treatment of ischaemic stroke. Expert Opin Biol Ther 2005; 5: 1547-1556.
41. Nakayama D, Matsuyama T, Ishibashi-Ueda H, et al. Injury-induced neural stem/progenitor cells in post-stroke human cerebral cortex. Eur J Neurosci 2010; 31: 90-98.
42. Chopp M, Zhang ZG, Jiang Q., Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 2007; 38: 827-831.
43. Martí-Fàbregas J, Romaguera-Ros M, Gõmez-Pinedo U, et al. Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology 2010; 74: 357-365.
44. Finklestein SP, Ren J,. Growth factors as treatments for stroke. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 259-266.
45. Zhang ZG, Chopp M,. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009; 8: 491-500.
46. Carmichael ST,. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol 2006; 59: 735-742.
47. Stowe AM, Plautz EJ, Eisner-Janowicz I, et al. VEGF protein associates to neurons in remote regions following cortical infarct. J Cereb Blood Flow Metab 2007; 27: 76-85.
48. Shen LH, Li Y, Chen J, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007; 27: 6-13.
49. Loubinoux I, Chollet F,. Neuropharmacology in stroke recovery. In:, Cramer SC, Nudo RJ, eds. Brain repair after stroke. Cambridge, UK: Cambridge University Press, 2010: 183-193.
50. Loubinoux I, Pariente J, Boulanouar K, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage 2009; 15: 26-36.
51. Rosser N, Floel A,. Pharmacological enhancement of motor recovery in subacute and chronic stroke. Neuro Rehabil 2008; 23: 95-103.
52. Liepert J,. Pharmacotherapy in restorative neurology. Curr Opin Neurol 2008; 21: 639-643.
53. Robinson RG, Adams HP Jr,. Selective serotonin-reuptake inhibitors and recovery after stroke. Lancet Neurol 2011; 10: 110-111.
54. Martinsson L, Eksborg S,. Drugs for stroke recovery: the example of amphetamines. Drugs Aging 2009; 21: 67-79.
55. Gladstone DJ, Danells CJ, Armesto A, et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006; 37: 179-185.
56. Platz T, Kim IH, Engel U, et al. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 2009; 23: 271-280.
57. Cramer SC,. Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. Int J Stroke 2011; 6: 315-316.
58. Adams HP, Robinson RG,. Improving recovery after stroke. Stroke 2012; 43: 2829-2832.
59. Narushima K, Robinson RG,. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression. Is there a time-related therapeutic window? J Nerv Ment Dis 2003; 191: 645-652.
60. Bilge C, Koçer E, Koçer A, Türk Börü U,. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med 2008; 44: 13-18.
61. Jorge RE, Robinson RG, Arndt S, Starkstein S,. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2004; 160: 1823-1829.
62. Tallelli P, Werring DJ,. Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients? J Neurol 2009; 256: 1159-1160.
63. Malberg JE, Schechter LE,. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des 2005; 11: 145-155.
64. Hunsberger J, Austin DR, Henter ID, Chen G,. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci 2009; 11: 333-343.
65. Tardito D, Perez J, Tiraboschi E, et al. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 2006; 58: 115-134.
66. Wang SH, Zhang ZJ, Guo YJ, et al. Notch1 signaling related hippocampal neurogenesis in adult poststroke depression rats: a valid index for an efficient combined citalopram and WAY100635 pharmacotherapy. Behav Pharmacol 2010; 21: 47-57.
67. Malberg JE, Eisch AJ, Nestler EJ, Duman RS,. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
68. Ampuero E, Rubio FJ, Falcon R, et al., Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience 2010; 169: 98-108.
69. Lim CM, Kim SW, Park JY, et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 2009; 87: 1037-1045.
70. Castren E, Rantamaki T,. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010; 70: 289-297.
71. Wang LE, Fink GR, Diekhoff S, et al. Noradrenergic enhancement improves motor network connectivity in stroke patients. Ann Neurol 2011; 69: 375-378.
72. Zittel S, Weiller C, Liepert J,. Reboxetine improves motor function in chronic stroke. A pilot study. J Neurol 2007; 254: 197-201.
73. Zittel S, Weiller C, Liepert J,. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008; 22: 311-314.
74. Simis S, Nitrini R,. Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke. Arq Neuropsiquiatr 2009; 64: 412-417.
75. Jorge RE, Acion L, Moser D, et al. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67: 187-196.
76. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 2009; 27: 1211-1214.
77. Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol Scand 2001; 50: 718-729.
78. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U,. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2009; 250: 347-351.
79. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2009; 157: 351-359.
80. Mikami K, Jorge RE, Adams HP Jr,. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011; 19: 1007-1015.
81. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10: 123-130.
82. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 2013; 44: 844-850.